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President
"Never doubt that a small
group of thoughtful,
committed individuals can change the world; indeed, it's the
only thing that ever has."
- Margaret Meade
Only four or five hospital networks in Southeastern Pa. are
expected to survive the economic challenges over the
next few years, according to a report by Standard &
Poor's.

Because of financial problems fueled by labor shortages, rising
drug prices, managed care pressures, Philadelphia's
population decline, the lack of a public hospital to treat the
uninsured, and the rising cost of malpractice, the report said,
marginal and weak hospitals may fail, while hospital networks
such as Jefferson Health System, University of Pennsylvania
Health System, Temple University Health System and Tenet
Healthcare Corp. are likely to emerge as the area's dominant
health care systems, reported the Philadelphia Inquirer.
Hospitals that remain independent are likely to face increasing
financial pressure, except for those that provide specialized
services, such as the Fox Chase Cancer Center, Wills Eye
Hospital, and Children's Hospital of Philadelphia, the
Philadelphia Inquirer noted. The study also found that
consolidation into larger networks has improved hospitals'
ability to negotiate better contracts with health insurers, drug
companies and other suppliers, but that narrow margins for
most hospitals will leave little money to invest in new medical
technology or equipment for patient care, the Philadelphia
Inquirer added. (Philadelphia Inquirer, May 2, 2001)
http:l/inq.philly.com/content/inquirer/2001/05/02/business/HOS
PS02.htm
While we are aware of the difficult financial challenges facing
hospitals in Pennsylvania, it is certainly sobering to read a
prediction (from presumably reliable S&P) that only a handful
of larger hospital systems in this region will be left standing
after a few years.
One of the continued sources of pressure is the Pennsylvania
malpractice crisis: "In the past two years, the cost of
mandated professional liability insurance for health care
providers has increased more that 30%. Those increases
coupled with rising premiums for primary liability coverage

have driven Pennsylvania's medical professional liability costs
40-70% higher than in surrounding states." (The Hospital and
Healthsystem Association of Pennsylvania- April2001)
(Continued on Page 2)

J
(Continued from Page 1)

Market forces are at woi'k in our Commonwealth:
};> Neurosurgeons - down 10% in each of the last two years
);;> Ob-Gyns- down 6.4% since 1997
- those delivering or assisting in delivering babies
down 7.5%
);;> Psychiatrists - down 11%
);;> Five times the number of Pennsylvania physicians retired
in 2000 as in 1999.
Thus, the malpractice premium increase is costing hospitals
and health systems, not just health care providers. All these
funds are flowing out of health care into an antiquated state
tort system that is begging for meaningful reform by our
Pennsylvania legislature. I am convinced that this problem is
now having a negative impact on our health care performance
as a state - and Pennsylvania is one of the last holdouts in the
nation against some type of tort reform. Our neighbors in New
Jersey, Delaware and New York do not share this problem;
this is only Pennsylvania.
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plan by 2004. LVHHN is not as far ahead of the curve as we
might think. Several regional hospitals have already been
using some variation of the CAPOE theme.

LVH·M
The Electronic Medical Record Access and Chart Completion
system (PIM 4.0) will be implemented on June 17, 2001.

Important Dates to Remember
June 4- old e-mail (7 year old green Screen) will no longer
print. Everyone is encouraged to switch over to the upgraded
Graphic user interface (GUI) e-mail.
June 17- LVH-M lmnet PIM 4.0
June 26 - TTU CAPOE

Growing old is mandatory; growing up is optional.

Physician Leadership
Life is the little shadow which runs across the grass and loses
itself in the sunset. Crowfoot - Last words, 1890

"I don1 get it- What's wrong with what we have now?
(overheard in the LVH hallways)
Ninety-five percent of physicians have witnessed a
serious medical error, and 58 percent of health care
providers say the health system is not very good.
According to respondents of a Robert Wood Johnson
Foundation survey of 600 physicians, 400 nurses and 200
senior-level hospital executives conducted in March and April,
61 percent of health care providers also said they accept
common errors as routine practice, while 29 percent said they
believe they can provide leadership to change the system,
USA Today reported. The foundation said it will spend $20.9
million over three years to fund Pursuing Perfection, an
initiative involving projects by hospitals and physician groups
to improve health care. ·The initiative has received more than
220 applications, 12 of which will get money to develop
business plans, and six will get up to $3.5 million to make
changes throughout their systems, USA Today added. (USA
Today, May 9, 2001)
http://www.usatoday.com/usatonline/2001 0509/3301962s.htm
Computer assisted physician order entry (CAPOE) is coming.
California has legislated that all hospitals in that state will have
a plan for CAPOE in place by 2002 and will implement that

At a time of ongoing change and instability in many areas of
health care, it is perfectly natural to feel uneasy and even
threatened. Everywhere we look, we can see change: drugs,
surgical techniques, outcomes analysis, education methods,
technology and now the OIM report suggesting that we change
the ENTIRE SYSTEM of care.
On the one hand, this is a time when the health care team
looks to the physician as the natural team leader for stability,
guidance and direction - and we can provide it because we
never forget that the focus of all these advances is improved
PATIENT care. The team looks to us for positive attitude and
we set the tone -like it or not.
On the other hand, physicians may be feeling queasy
themselves about digesting all this change. Your medical staff
leadership is very concerned about providing support
mechanisms and safety nets (with each change) so that no
one will be left behind - unless, of course, they choose that
path. We will progress as a medical staff and an institution
together.

You have to dance like nobody's watching and love like it's
never going to hurt. - Source unknown.

(Continued on Page 3)
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Monitored Anesthesia Coverage (MAC) • Medicare Rule
Changes

Effective April 29, 2001, Medicare requires supporting
documentation to justify MAC anesthesia for surgical or
diagnostic procedures involving the entire integumentary
system, including biopsies, excision of masses, colonoscopies
and endoscopies. Medicare also requires supporting
documentation for MAC anesthesia for MRI's. Medicare does
not require justification when General anesthesia or Propofol
infusions are used for these procedures. Basically, if the
procedure is done with minimal or light sedation, Medicare is
requiring that the attending surgeon (gastroenterologist, etc.)
justify an additional payment for the anesthesia component.
Some of the diagnoses that Medicare will accept as
justification for anesthesia reimbursement for light (MAC)
sedation include:
CAD
Severe anxiety
Acute or chronic respiratory diseases
CVA
Diabetes
Renal disease
To obtain a copy ofthe MAC Medicare Policy, please contact
Janet M. Seifert in Physician Relations at (610) 402-8590.

Golfer: "I've played so poorly all day; I think I'm going to
drown myself in that lake."
Caddie: "I don't think you could keep your head down that
long, Sir."

Edward M. Mullin, Jr., MD
Medical Staff President

You are cordially invited to attend
a VIP Reception at
Lehigh Valley Hospital and Health Network's
Newly Expanded Sleep Disorder Center
on Wednesday, June 13, 2001
3 to 7 p.m.
1T"" & Chew Streets
Fourth Floor
RSVP (610) 402-CARE by June 6
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A meeting of the General Medical Staff will be held
on Monday, June 11, beginning at 6 p.m. in the
Auditorium of Lehigh Valley Hospital, Cedar Crest
& I-78, and via videoconference in the First Floor
Conference Room at LVH-Muhlenberg. All members
of the Medical Staff are encouraged to attend.
In conjunction with the General Medical Staff
meeting, a Health Care Technology Fair will be held
from 5:30 to 8 p.m., in the Anderson Wing Lobby at
Cedar Crest & I-78. Displays and demonstrations
will be available. Please plan to stop by for a few
minutes before or after the meeting. Door prizes
wi II be awarded.

Physician Satisfaction by David M. caccese, MD
As representatives of the Medical Staff, the members of Troika
recently met with Nancy Stevens and Maryanne Falcone,
Patient Representatives, and Jack Dunleavy from
Organizational Development, to discuss the LVH Medical Staff
physician satisfaction scores on the Press-Ganey surveys,
which our hospitalized patients are asked to complete about
two weeks after their discharge from the hospital. We learned
a number of important things that I'll be sharing with you over
the next few months.
Most importantly, patients value the time we spend in their
rooms at the bedside. This is "face-to-face" time. It gives the
patient an opportunity to ask questions of their doctor, have
those questions answered, and to have the plans for the
remainder of the hospital stay addressed. Sitting in the room
with the patient makes an even bigger difference in the
patient's perception of the time and interest that the physician
demonstrates for his/her problem.
It's frightening to learn that many patients are unable to name
their physicians. There are multiple reasons for this surprising
fact. Patients are sometimes referred into the hospital by their
personal physicians to be cared for by "specialists" who they
may never have seen before. The specialists often work with
multiple partners who may see the patient on different days
during their hospital stay. Patients are frequenHy very ill and
simply can't remember all of the physicians and staff who stop
into their rooms.
A simple solution to these problems is to be sure to introduce
yourself to the patient when you come to the bedside. Tell
them with whom you work. Tell them why you are there. Give
them your professional card with your name and your group's
name clearly indicated. By following these simple suggestions,
our patients will be more likely to remember our names.

Notes

News from CAPOE Central
We are getting close to the activation date for the LastWord
upgrade on June 16, and the TTU will go live wit~ CAPOE by
the end of the month. The Design Team had the1r last meeting
on May 18, and is on a very well deserved hiatus until after golive. We will re-convene the Design Team to discuss the
system after TTU gains some experience with CAPO E.
Although full implementation of CAPOE throughout the
hospitals will take some time, many of ~he physicians. and .
providers will be affected when consulting on or working With
CAPOE patients. The expectation is that physicians and
providers will review orders and sign telephone orders fo.r
CAPOE patients in the computer system. A benefit of th1s
change is that physicians will be able to perform these
functions from anywhere with LastWord access.
Various modes of education and training will be provided for
these improvements in the information systems. Of particular
interest to physicians in the LastWord training will be the new
Patient Lists, Medication Profile, Order Review, and the Viewer
(to look up labs, etc.). For a list of training dates, please refer
to the article on page 5.
There will also be web-based training available for the
LastWord upgrade. Users will be able to access this
interactive training system at any time from any PC with a
browser (in the hospital or at home). This will allow the users
to receive training as it is needed, and refresh their education
when necessary.
CAPOE Training
Training for CAPOE physicians and other providers will occur
through several channels. The majority of the training will be
one-on-one with users when their units in the hospital are
ready to go-live with CAPOE. There are three excellent
physician educators who will be available to meet with
physicians at their convenience to provide training and ongoing
support. There will be a very user-friendly reference guide that
all CAPOE physicians will receive. It will walk the physician
through the system and provide illustrations on how to use the
system. A pocket guide will also be available that will illustrate
the key points to Physician Order Entry.
Live demonstrations, providing hands-on opportunities, will be
available during the following times.
June 5
June 11
June 13

7 a.m. to 5 p.m. Anderson Wing
5:30 to 8 p.m.
Anderson Wing
7 a.m. to 5 p.m. Anderson Wing
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1urge all physicians to participate in the training. These new
systems will improve patient care and ultimately make our lives
easier.
Please call me with any questions or if you would like a
demonstration of CAPOE.
Don Levick, MD, MBA
(484) 884-4593 (office)
(610) 402-5100 7481 (pager)

Interested in Looking up Info on Your
Patients from Anywhere???
If so, Channel Health provides a secured way to have access to
IDX Lastword (Phamis) patient information in a read-only mode
through the Internet. All you need is an Internet connectio~
and Internet Explorer 5.0. Also included in ChanneiHealth 1s
Physician Homebase. This provides you with predefined (and
easily customizable) links to medical journals, medical
specialties, medical associations, government health sites,
MDConsult, Continuing Medical Education (CME) credits, and
MORE.
For more information, please stop by the display after the
General Medical Staff meeting on June 11, at Cedar Crest &
1-78, or in the First Floor Conference Room at Lehigh Valley
Hospital-Muhlenberg on June 28 from 7 a.m. to 5 p.m. If you
cannot attend either of these showings, please contact the 1/S
Helpdesk at (610) 402-8303 and ask for the Physteam. The
Physteam can schedule an appointment to demonstrate this
for you at a more convenient time.
The next Greater Lehigh Valley Independent
Practice Association Quarterly General
Membership Meeting will be held on Monday, June
25, at 6 p.m., in the hospital's Auditorium at Cedar
Crest & I-78.
This meeting will include information regarding the
expanded vendor program. The LVPHO Preferred
Vendor Program is entering into a partnership with
the alternative care division of VHA, known as
LaurusHealth Professional, a national purchasing
organization. Your office manager is also invited to
attend this portion of the meeting, from 6 to 6:30
p.m., to learn how the program works.
Reminder: To receive credit for your attendance,
please remember to sign in.
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IDX LastWord Physician Training
Education and training for improvements to the lOX LastWord
information system, including use of the new Patient Lists,
Micro Command, Medication Profile, Order Review, and the
Viewer (to look up labs, etc.), will be provided as noted below.
Attendance at any of the following sessions will cover what will
be needed for physicians to use the new features of lOX
LastWord, which will be implemented on June 16, 2001. In
addition, members of the Information Services staff will be
available, around the clock, in the Medical Staff Lounge at
Cedar Crest &1-78 and LVH-Muhlenberg from "go-live" on
June 16 through June 18 to assist physicians and to answer
questions.
Classroom type training for the LastWord upgrade will occur at
the following times and locations:

Cedar Crest & 1-78
JuneS
Learning Resource Center - CC Library
7 to 8 a.m.
noon to 1 p.m. Learning Resource Center- CC Library
Learning Resource Center- CC Library
6 to 7 p.m.
June7
Learning Resource Center- CC Library
?to 8 a.m.
noon to 1 p.m. Learning Resource Center- CC Library
Learning Resource Center - CC Library
6 to 7 p.m.
June 11
Learning Resource Center- CC Library
?to 8 a.m.
noon to 1 p.m. Learning Resource Center- CC Library
Learning Resource Center- CC Library
6 to 7 p.m.
June 13
7 to 8 a.m.
Learning Resource Center- CC Library
noon to 1 p.m. Learning Resource Center - CC Library
4:30 to 5:30 p.m. JDMCC 4th Floor 1/S Training Room
6 to 7 p.m.
Learning Resource Center- CC Library
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Lehigh Valley Hospital-Muhlenberg
June7
Information Services Training Room- LVH-M
7 to 8 a.m.
noon to 1 p.m. Information Services Training Room- LVH-M
Information Services Training Room - LVH-M
6 to 7 p.m.
June 13
noon to 1 p.m. Information Services Training Room- LVH-M
June 14
4:30 to 5:30p.m. Information Services Training Room- LVH-M
17"' &Chew
JuneS
6th Floor CEDS Conference Room - 17
7 to 8 a.m.
noon to 1 p.m. 6th Floor CEDS Conference Room - 17
6th Floor CEDS Conference Room - 17
6to 7 p.m.
June 12
6th Floor CEDS Conference Room - 17
?to 8 a.m.
noon to 1 p.m. 6th Floor CEDS Conference Room -17
6th Floor CEDS Conference Room - 17
6to 7 p.m.
Live demonstrations - providing hands-on opportunities will
be available during the following times:
June 5 - 7 a.m. to 5 p.m. - Anderson Wing, Cedar Crest &1-78
June 11 - 5:30 to 8 p.m. - Anderson Wing, Cedar Crest &1-78
(in conjunction with the General Medical Staff meeting)
June 13- 7 a.m. to 5 p.m. -Anderson Wing, Cedar Crest &1-78
There will also be web-based training available for the
LastWord upgrade. Users will be able to access this
interactive training system at any time from any PC with a
browser {in the hospital or at home). This will allow the users
to receive training as it is needed, and refresh their education
when necessary.
Please email or call Craig Koller in the Center for Education at
(61 0) 402-2413 with any scheduling questions.

June 14
noon to 1 p.m. JDMCC 4th Floor 1/S Training Room
June 15
7 to 8 a.m.
JDMCC 4th Floor 1/S Training Room
noon to 1 p.m. JDMCC 4th Floor 1/S Training Room
June 18
noon to 1 p.m. Learning Resource Center- CC Library
June 19
noon to 1 p.m. Learning Resource Center- CC Library

If you missed the Advanced Directives Fair and
would like a packet of information geared to the
needs of physicians, please contact Nancy Stevens,
Patient Representative, at (610) 402-8222 or via
e-mail. Included in the packet are sample
directives and articles about talking with patients
regarding their medical treatment wishes.

June,2001
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Setting Up Your Default Patient List

diabetic patients in your Hotlist). Since patients are added to
the Hotlist, upon initial entry no patients appear in the list.

The first time you access Lastword 4.1. 7, you will note an
asterisk (*) next to the Hotlist name in the Patient List Directory
window (see Figure 1). This indicates Hotlist Is assigned as
your default patient list. Hotlist is a user defined list that may
be used for tracking purposes (e.g., you can include all

For practical purposes, it is best to change the default patient
list to MyCensus. MyCensus is a system defined list of
patients by physician group (i.e., all patients followed by your
physician group are included in this list).

Note asterisk
next to Hotlist

Make Default
button

Figure 1 • The Physician Base Screen appearance when logging on the first time

To change your default patient list from Hotlistto
MyCensus:
1.

Click on MyCensus list name in the Patient List
Directory window. The MyCensus list name
highlights.

2.

Click on the Make Default button located beneath the
Patient List Directory window. Note the asterisk that
appeared adjacent to Hotlist is now next to
MyCensus.

Your default patient list is now MyCensus. Note in Figure 2 on
Page 7 the Current Patient List window now contains the
patients belonging to MyCensus. Also note the MyCensus list
name located above the Current Patient List window.
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5C038 PASQUALE. MICHAEL
7A048 LEVICK. DONALD L
7C 01 LEVICK. DONALD L

TT 02 LEVICK. DONALD L
TT 03 LEVICK. DONALD L
TT 04 LEVICK. DONALD L

Note asterisk next
to MyCensus

Figure 2 • Physician Base Screen appearance after changing default patient list to MyCensus

The Children's Hospital of Philadelphia
Specialty Care .Center of the Lehigh
Valley
The new Children's Hospital of Philadelphia Specialty Care
Center of the Lehigh Valley, a joint effort between CHOP and
LVHHN, opened its doors to children in the community on
February 12. Located on the campus of Lehigh Valley
Hospital-Muhlenberg, the Specialty Care Center provides area
families access to many pediatric specialty services, including
oncology, endocrinology, pulmonary, cardiology and
orthopedics, allowing children to stay closer to home for
specialty outpatient care.
The new, two-story facility includes a new ambulatory surgical
suite at ground level and the Specialty Care Center on the
upper floor. The child-friendly specialty care facility is
equipped with 17 exam rooms, two procedure rooms, a
therapy gym, and a pulmonary function lab. Adjacent to the

main waiting room is a Family Resource Center-- a
comfortable and inviting place where patients, parents and
siblings can obtain more information about health topics of
interest. The Family Resource Center is equipped with the
latest pediatric healthcare publications and education
information, plus a video library and viewing area, and several
computers with relevant pediatric healthcare Web sites
convenienHy bookmarked.
Hours of operation for the Specialty Care Center are Monday
through Friday, 8 a.m. to 5 p.m. For more information or to
schedule appointments, please call (484) 884-CHOP.

A special Family Fun Day to introduce the Specialty
Care Center and its services to the community will take
place on Saturday, June 2, from 11 a.m. to 3 p.m., at
the new facility. Activities for children, entertainment and
food, as well as tours of the new facility will be included in
the day's events.
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Radiology News
PET Update
Early last month, the Section of Nuclear Medicine began to
provide PET scan serviCes at Lehigh Valley Hospital, Cedar
Crest &1-78. The first patient had a 1.2 em. solitary pulmonary
nodule which was benign by PET criteria. This saved the
patient unnecessary biopsy, and the patient will be followed by
serial CAT scans. The second patient had an indeterminate
lesion in the perirectal area on serial MRI scans. The PET
scan showed this to be consistent with recurrent tumor in this
region, and the patient will receive aggressive therapy. The
next three patients all had solitary pulmonary nodules, all of
which were positive by PET criteria, and biopsies will be
performed on these patients for histologic diagnosis.
PET scans will replace Neotect scans for the workup of solitary
pulmonary nodules and will replace CEA scans for the workup
of recurrent colorectal carcinoma since PET has been shown
to be more sensitive in these cases. In addition, PET scans
are more sensitive than gallium scans for staging Hodgkins
and Non-Hodgkins lymphoma and are recommended for this
purpose. On the other hand, Prostascint scans are still
recommended for staging of recurrent prostate cancer since
PET has not been shown to be as effective in the evaluation of
these patients.

One use is differentiating neoplasm from a non-neoplastic
process such a demyelinating disease, infarction, infection, or
radiation necrosis. While any of these may produce a masslike appearance with conventional imaging, their spectra can
be markedly different. MR spectroscopy is also useful in the
diagnosis and management of certain metabolic diseases.
At Lehigh Magnetic Imaging Center, three of the high field 1.5
Tesla magnets are specially equipped to perform
spectroscopy. MRS can be performed as an adjunct to
conventional MR imaging.
If you have any questions regarding MR spectroscopy or its
potential use for any of your patients, please contact Elliot I.
Shoemaker, MD, Vice Chairperson, Department of RadiologyDiagnostic Medical Imaging, at (610) 402-8088.

Coding Tip of the Month
To code wound repairs more accurately,
the following should be documented in the
medical record:
)o>

Currently, the state-of-the-art mobile PET scanner is available
at LVH once a week. Patients can be scheduled by calling
(610) 402-TEST and by following the prompts. PET scans are
performed on an outpatient basis for the following criteria:
solitary pulmonary nodules, staging of non small cell lung
cancer, staging and work-up of lymphoma, recurrent colorectal
cancer, and melanoma.
If you have any questions regarding PET scans, please
contact either Kathleen L. McDonald, MD, or Robert J. Rienzo,
MD, in Nuclear Medicine at (610) 402-8373.
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)o>
)o>
)o>

)o>

Number of wounds repaired.
Anatomical sites of the wounds.
Length of wounds (in centimeters).
What type of repairs were performed:
Simple, Intermediate, Complex, etc?
Was tendon, nerve, or blood vessel
repair involved?

Magnetic Resonance Spectroscopy
Magnetic resonance spectroscopy (MRS) is a non-invasive
means of measuring metabolites within tissue. Currently, its
main applications have been in studies of the brain. Rather
than generating an image, MR spectroscopy produces a graph
that measures the presence of specific metabolites.
Comparisons of the concentration of different metabolites in
the abnormal brain can help differentiate disease processes
that may have a similar appearance with conventional MRI
imaging.

On May 23, the Special Care Unit at Cedar
Crest & I-78 relocated from the sixth
floor to the second floor of the main
hospital, adjacent to the Emergency
Department. The telephone number has
remained the same -- (610) 402-8730.
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'7he Difference"
by George A. Arangio, MD
It has been a busy 25 years at Lehigh Valley Hospital. It was a
time of change for all of us. However, some things do not
change. Our patients are dependent on our care and on our
caring. It is a stressful commitment, and the responsibility is
great. We divert ourselves from the unavoidable demands of
our profession with our hobbies and our toys, some of us more
successfully than others. The pressures are ever present.
It was time for an examination and renewal. I needed to
assess where and what I wished to be. As I rested from my
successes and searched, I found the significance in what we
do; the effort was therapeutic.

9

In Bella Bologna the "ricercare, • the sabbatical, the search
1. am a continent away, but the scene is eerily
s1m1lar. Am1dst the beauty, elegance and antiquity, the
surgical work is completed with excellence. At the lstituto
Ortopedico Rizzoli, the workdays are long, and the pace is
surprisingly American; however there are notable distinctions.
The paperwork is pertinent and, therefore, less. Medical
insurance is one-tenth of the cost compared to costs in
America. There is a rigid medical hierarchy and the financial
rewards are usually smaller. But, some things do not change.
The stresses to deliver good care and to advance
professionally and financially are obvious. The introspective
Italians share their hearts with whoever will listen.
c?n~inues.

•And how is it in America?" they ask.
"About the same,• I respond.

It is seven o'clock in the morning of July 10, 2000 at the Union
Memorial Hospital. I am a visiting foot and ankle clinician. Ten
hours later, my colleagues and I have seen 70 patients. I am
relaxed, smiling and satisfied. I am a physician observer "with
no patient responsibility." Forced detachment is the difference;
however, some things do not change. My host and his staff
are completing their work: diagnosing and treating, casts off
and casts on, record keeping, scheduling, billing, insurance
forms, messages and questions.
"Mrs. Jones, if you are going to speak to me in that tone, I will
have to hang up the phone!" says one secretary.
!~e

care and the caring are accomplished. It is important, and
1t 1s stressful. It goes on for four weeks, and I love each day.
Being on sabbatical is different!

I ~alk to work on a sunny, cool, August morning in Rochester,
Minnesota. My colleagues receive me warmly, and I am
assimilated among 12 research scientists and the Mayo
Orthopedic staff. There is pressure in this easygoing midwestern medical community. Their mission is to care for
patients, teach, complete research and publish. The libraries
are jammed until late evening, and the computers "hum•
endlessly. I wrestle with my assigned keyboard, day and night,
Saturdays and Sundays, but it is a leisure endeavor. There
are. no pressing deadlines, no grant applications, and no
pat~~nt care respons!bilities. I am working, reflecting and
sm1hng. I am tranquil while being productive. I will try to
convey the experience to whoever will listen. It is different.

It was a wonderful experience to assist my Italian colleagues in
their work and share their friendship.

The last quarter of my sabbatical was spent at the Carolina's
Medical Center in Charlotte, North Carolina. The Southern
born and bred were friendly companions. Good manners and
a smile are prerequisites in the South. Nowhere was there
more pressure to get the medical work completed than in
pleasant Charlotte. The physicians and staff worked long
hours, solved difficult problems, and were driven caregivers.
Some were transplanted from the North. You could tell who
was ~rom where! For m~, i~ was another six weeks of learning,
meeting people, and enJOYing the difference.

~am home once. ~ore practicing orthopedic surgery. It is
Intellectually, sp1ntually, and physically demanding. I have
confirmed that our greatest assets are the people with whom
we work. I have learned that some of our stresses are selfinflicted. I shall periodically step away to stop to look and
listen: ~t is.refreshing, relaxing and therapeutic. I appreciate
the d1st1nction between success and significance.

My "Modest Proposal" is that all physicians must take six
months sabbatical every seven years.

Ju

Good Shepherd Specialty HospitalAllentown
Following is an overview of the Good Shepherd Specialty
Hospital-Allentown for the time period of July 1, 2000 through
March 31,2001.
~

Occupancy - 43.9%

Admissions to Programs
~
~
~
~

Pulmonary/ventilator- 38
Complex medical-·1 04
Transitional rehabilitation - 22
Average length of stay- 25.31 days

Discharge Destinations
~
~
~
~
~
~
~
~
~

Home-48
Rehab- 22
Subacute 3
Skilled- 29
Assisted Living - 3
Planned readmissions - 8
Acute unplanned - 19
Inpatient Hospice- 1
Expired- 19

Total Discharges - 152

Number&
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Congratulations!
Karen A. Bretz, MD, Vice Chairperson for Quality Assurance,
Department of Anesthesiology, was recently informed that she
was selected to attend the professional development program
-- "Mid Career Women Physicians" -- which will be held July
21-23 in Washington, DC. Jointly sponsored by the
Association of American Medical Colleges and Harvard
Medical School, the program has a competitive application
process with admission limited to one or two individuals per
organization.

Papers, Publications and Presentations
Kelly M. Freed, MD, Division of Diagnostic Radiology, coauthored two articles which were published in the April, 2001
issue of the American Journal of Roentgenology. The first
article, "The Spectrum of Abdominal Venous CT Findings in
Blunt Trauma," reviews common venous injuries such as
mesenteric hematomas, portal and hepatic vein injuries, as
well as uncommon ones such as contained rupture of the IVC
and traumatic fat herniation into the IVC. The other article is
titled "The Anterior Iliac Separation: Alternative Index for
Pelvic Morphometry in Fetuses with Down Syndrome." A
widened iliac angle has been proposed as a marker for Down
Syndrome on prenatal sonography by several investigators.
This is the first article to investigate the linear measurement of
the anterior iliac separation - the linear correlate of the iliac
angle - which is simpler to measure and more reproducible.
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New cardiac program underway
All beds have telemetry capability
Nurses attend LVH cardiac training classes
231 Physicians on staff

FYI
Medical Records - See charge nurse for after-hour requests
Key Contacts
Don Yoder- Administrator/CEO- (610) 402-8559
Beverly Snyder- Director of Nursing/Assistant Administrator(610) 402-8564
Tammy Winterhalt- Medical Staff Coordinator- (610) 4028564
Angela Ritter- Director HIM/Outcomes- (610) 402-7674
Lisa Marsilio- Physician/Community Education- (610) 4028490

Mark A. Gittleman, MD, Division of General Surgery, was an
invited speaker at the Annual Mastology Conference held April
18-22, in Rosario, Argentina. Dr. Gittleman's topics included
"Current Status of Sentinel Node Biopsies in Breast Cancer
Diagnosis,• and "The United States Experience with Tamoxifen
Trials." Dr. Gittleman was also an invited speaker at the
American College of Surgeons Spring Meeting in Toronto,
Canada, on April 23. He spoke at the Breast Ultrasound PostGraduate Course discussing "lnterventional Breast
Ultrasound." In addition, he was a guest speaker at the Annual
Meeting for the American Society of Breast Surgeons held May
2-6 in La Jolla, Calif. Dr. Gittleman presented lectures on
Stereotactic Breast Biopsy and Breast Ultrasound Certification
programs.
Barry H. Glassman, DMD, Division of General Dentistry,
presented "The Use of EMG and Electrognathology in
Craniomandibular Therapy" at the BioResearch TMD Annual
Workshop Conference held in early May in Milwaukee, Wis.
(Continued on Page 11)
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Geoffrey G. Hallock, MD, Division of Plastic Surgery, recently
had an article published in the Journal of Plastic and
Reconstructive Surgery titled "A Prospective Study of the
Accuracy of the Surgeon's Diagnosis and Significance of
Positive Margins in Non-Melanoma Skin Cancers." This was
an office-based experience with the removal of more than
2,000 tumors showing that at least for non-horrifying skin
cancers, which are very common, that only routine clinical
follow-up rather than surgery or any other adjunct modality was
usually sufficient long term to monitor those lesions, even if
residual tumor had been noted on the pathologic exam.
lndru T. Khubchandani, MD, Division of Colon and Rectal
Surgery, was invited to operate and to speak at the 81h Biennial
Congress of European Council of Coloproctology in Prague,
Czech Republic, from April 29 to May 2. Dr. Khubchandani
performed two hemorrhoidectomies and a procedure for
fissure in ano in the operating room of Motel Hospital, which
were telecast live to the auditorium of the Congress. Dr.
Khubchandani was later interviewed by the media to give his
impression regarding the facilities for surgery available in the
Czech Republic. The story appeared on the front page of the
local newspaper in addition to being publicized on national
television. Later that week, Dr. Khubchandani chaired a panel
on Anal Diseases and participated in symposia for
hemorrhoids and laparoscopic surgery.
On April16, Vincent R•. Lucente, MD, Acting Chairperson,
Department of Obstetrics and Gynecology, was a guest
speaker at the Bronx Gynecological and Obstetrical Society on
the topic tiHed "Minimally Invasive Approaches to Stress
Urinary Incontinence." Dr. Lucente was also invited to
participate as visiting faculty for a symposium on
"Comprehensive Gynecologic Laparoscopy" hosted by the
University of Texas Southwestern Medical Center, April 27-28.
In addition to presenting lectures, Dr. Lucente performed live
telesurgery in Dallas. He was also the course director of the
laparoscopy skills development lab. In addition, Dr. Lucente
served as faculty director for a post-graduate course titled
"Surviving the Business of Medicine" at the American College
of Obstetrics and Gynecology's 50th Anniversary Clinical
Meeting held April 28 to May 2 in Chicago, Ill. He also
presented a clinical seminar titled "Vaginal vs. Abdominal vs.
Laparoscopic Correction of Pelvic Support Defects."
Thomas D. Meade, MD, Division of Orthopedic Surgery,
Section of Ortho Trauma, was awarded the best paper
presentation at the Pennsylvania Orthopaedic Society meeting
held recently in Miami, Fla. Dr. Meade's presentation was
titled "A New Approach ·to an Old Problem: Clavicle Fracture When to Operate?"
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Michael D. Pasquale, MD, Chief, Division of General Surgery
and Trauma-Surgical Critical Care, and Thomas E. Wasser,
PhD, Director of Clinical Epidemiology, coauthored the paper,
"Outcome Analysis of Pennsylvania Trauma Centers: Factors
Predictive of Nonsurvival in Seriously Injured Patients," which
appeared in the March issue of The Journal of Trauma.
Carmine J. Pellosie, DO, MPH, Chief, Section of
Occupational Medicine, was a key speaker at a breakfast
seminar on April18, where he presented issues concerning
ergonomics after the repeal of the OSHA regulations.
Representatives from Good Shepherd Outpatient
Rehabilitation Clinic and Air Products and Chemicals, Inc., also
presented. Individuals from regional, national, and
international companies attended to learn about OSHA
ergonomic information, ergonomic programs, and workplace
job analysis.
Robert D. Riether, MD, Program Director, Colon and Rectal
Surgery Residency Program, and Herbert C. Hoover, Jr, MD,
Chairperson, Department of Surgery, co-authored the review,
"Hepatic Arterial Infusion Chemotherapy," which appeared in
the March/April 2001 issue of Current Surgery.
Lester Rosen, MD, Division of Colon and Rectal Surgery, was
an invited speaker for the spring meeting of the Northeast
Society of Colon and Rectal Surgeons held April27-29, in
Providence, Rl. Dr. Rosen discussed the applications of
"Virtual Colonoscopy as it Relates to Colonoscopy Cancer
Screening." Additionally, Dr. Rosen was a co-author of the
article, "Computerized Assessment of Complications Following
Colorectal Surgery," which appeared in the April issue of
Diseases of the Colon and Rectum. Computer software was
analyzed to determine whether its predictions of co-morbidity
and complications were comparable to what was interpreted in
the medical record. The conclusion was that these predictions
were quite accurate. As the uniformed discharge coding of
commingled co-morbidity and complications is increasingly
used to rapidly compute surgical outcomes, colon and rectal
surgeons were urged to ensure compatibility of the actual and
coded medical record.
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Upcoming Seminars, Conferences and
Meetings
Medical Grand Rounds
Medical Grand Rounds are held on Tuesdays beginning at
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest
&1-78, and via videoconference in the First Floor Conference
Room at Lehigh Valley Hospital-Muhlenberg.
Topics to be discussed in June will include:
~ June 5 - Current Residency Research Projects
~ June 12 - "Update in Therapies for Rheumatoid Arthritis"
Have a great summer! Medical Grand Rounds will resume on
September 4.
For more information, contact Diane Biernacki in the
Department of Medicine at (610) 402-5200.

Pediatric Grand Rounds
"Controversies Surrounding UTI's" will be presented on
Tuesday, June 26, beginning at 8 a.m., in the hospital's
Auditorium at Cedar Crest & 1-78.
For more information, please contact Kelli Ripperger in the
Department of Pediatrics at (610) 402-2540.

Who's New
The Who's New section of Medical Staff Progress Notes
contains an update of new appointments, address changes,
resignations, etc. Please remember to update your directory
and rolodexes with this information. In addition, the Medical
Staff Directory is now available on the e-mail Bulletin Board -Directories. Updates will be made to the Medical Staff
Directory in e-mail at the beginning of each month.

Medical Staff
Appointments
Andrew K. Feng, MD
(Solo Practice)
1 Duke Lane
Ambler, PA 19002-1522
(215) 793-9686
Department of Pediatrics
Division of Hospital Based Pediatrics
Section of Critical Care .Medicine
Site of Privileges - LVH & LVH-M
Provisional Limited Duty

Maryann P. Hartzell, DPM
Allentown Family Foot Care
1633 N. 26th Street
Allentown, PA 18104-1801
(610) 434-7000
Fax: (610) 434-7029
Department of Surgery
Division of Orthopedic Surgery
Section of Foot and Ankle Surgery
Site of Privileges - LVH-M
Provisional Active
John J. Scaffidi, Jr., MD
Total Women's Health Care
2200 W. Hamilton Street, Suite 103
Allentown, PA 18104-6329
(610) 821-8321
Fax: (610) 435-4599
Department of Obstetrics and Gynecology
Division of Primary Obstetrics and Gynecology
Site of Privileges - LVH &LVH-M
Provisional Active
Jay D. Varrato, DO
Lehigh Neurology
1210 S. Cedar Crest Blvd., Suite 1800
Allentown, PA 18103-6208
(610) 402-8420
Fax: (610) 402-1689
Department of Medicine
Division of Neurology
Site of Privileges - LVH &LVH-M
Provisional Active

Practice Changes
Lori A. Barnett, DPM
(Now in practice with Coordinated Health Systems)
1401 N. Cedar Crest Blvd.
Suite 103
Allentown, PA 18104-2307
(610) 433-8080
Fax: (610) 433-4376
Meera Pathare, MD
(No longer with Whitehall Medical Center)
Drs. Bub and Young Family Medical Center
619 Dalton Street
P.O. Box 899
Emmaus, PA 18049-0899
(610) 967-3646
Fax: (610) 965-6595
(Continued on Page 13)
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Robert D. Riether, MD
(No longer with KSSRR, PC)
Now in solo practice
1230 S. Cedar Crest Blvd.
Suite 303
Allentown, PA 18103-6212
(610) 402-1700
Fax: (610} 435-5003
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Nancy L. Minnich, PA-C
Physician Extender
Physician Assistant- PA-C
(Coordinated Health Systems - Leigh S. Brezenoff, MD)
Site of Privileges - LVH-M
Pamela K. Monceaux, CRNP
Physician Extender
Professional - CRNP
(LVPG-Neonatology -lan M. Gertner, MD}
Site of Privileges - LVH & LVH-M

Status Change
Bruce A. Frankenfield, MD
Department of Medicine
Division of General Internal Medicine
From: Affiliate
To: Honorary

One-Year Leave of Absence
Dennis W. Kean, MD .
Department of Pediatrics
Division of General Pediatrics
From: Active
To: Active/LOA
Michael A. Renaldo, DDS
Department of Surgery
Division of Oral and Maxillofacial Surgery
From: Active
To: Active/LOA

Allied Health Professionals
Appointments
Michael D. Figard, PA-C
Physician Extender
Physician Assistant- PA-C
(Orthopaedic Associates of Allentown- James C. Weis, MD)
Site of Privileges - LVH & LVH-M
Lori E. Holliday
Physician Extender
Technical
(The Heart Care Group, PC - Joseph L. Neri, DO)
Site of Privileges - LVH &LVH-M

Daniel M. Schwartz, PhD, DABNM
Associate Scientific
Clinical Neurophysiologist
(Surgical Monitoring Associates)
(Supervising Physician - Mar1< C. Lester, MD)
Site of Privileges - LVH & LVH-M
Sandra K. Stufflet, RN
Physician Extender
Professional - RN
(The Heart Care Group, PC - Steven Zelenkofske, DO)
Site of Privileges - LVH & LVH-M
Jennifer B. Wall, PA-C
Physician Extender
Physician Assistant- PA-C
(Muhlenberg Primary Care, PC - Iqbal Sorathia, MD)
Site of Privileges - LVH & LVH-M

Change of Group and Supervising Physician
Catherine E. Donati, CRNP
Physician Extender
Professional - CRNP
From: Hamburg Family Practice Center
To: Allentown Anesthesia Associates Inc- Lisa A. Keglovitz,
MD
Site of Privileges - LVH & LVH-M

Resignations
Laurie A. West, PA-C
Physician Extender
Physician Assistant- PA-C
(HealthWor1<s)
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THERAPEUTICS AT A GLANCE
The following actions were taken at the Apri12001 Therapeutics Committee Meeting- Joseph Ottinger, R.Ph., MS, MBA, Christopher
Moore, Pharm. D., Janine Barnaby, R.Ph., Jenny Boucher, Pharm.D.

Drug Formulary IssuesBivalrudin, estrogen patches
BWALIRUDIN/ANGIOMAX ™
INDICATIONS: Bivalirudin is indicated for use
as an anticoagulant in patients with unstable
angina undergoing percutaneous transluminal
coronary angioplasty (PTCA). It is intended for
use with aspirin and has only been studied in
patients receiving concomitant aspirin.
The safety and effectiveness ofbivalirudin has not
yet been established in conjunction with platelet
inhibitors other than aspirin, such as glycoprotein
lib/lila inhibitors, or in patients with unstable
angina who are not undergoing PTCA, or in
patients with other acute coronary syndromes,
although studies have recently been completed or
are underway evaluating bivalirudin in these
settings.
CLINICAL PHARMACOLOGY: Bivalirudin
(hirulog) is a 20 amino acid synthetic peptide
reversible direct thrombin inhibitor modeled after
the protein hirudin. It is a bivalent inhibitor of
thrombin, binding to both the anion-binding
exosite and enzyme catalytic site on both soluble
and clot-bound thrombin.
Unlike heparin,
bivalirudin does not require a cofactor (eg,
antithrombin III) to produce its antithrombin
activity.
Bivalirudin transiently inhibits the active site of
thrombin. Like lepirudin, it binds both the active
site and exosite 1 on thrombin. Once bivalirudin
is bound, thrombin slowly cleaves the bond on the

amino-terminal domain of bivalirudin, which
eliminates the active site inhibition. It remains
bound to the exosite 1; however,· this is a low
affinity interaction. Overall, unlike lepirudin,
bivalirudin produces only transient inhibition of
thrombin.
Intravenous administration of bivalirudin
produces a rapid, dose-dependent prolongation of
activated clotting time (ACT), activated partial
thromboplastin time (APTT), prothrombin time
(Pn, and thrombin time (TT)
PHARMACOKINETICS: Bivalirudin exhibits
linear pharmacokinetics following intravenous
administration. Bivalirudin blood levels have
correlated with APTT, PT, and activated clotting.
Bivalirudin is rapidly cleared, following
intravenous administration, with a half-life of25
minutes in patients with normal renal function. It
is cleared from the plasma by a combination of
renal mechanisms and proteolytic cleavage·
Urinary excretion accounted for approximately
20% of the total dose administered, regardless of
route.
Bivalirudin elimination correlates with glomerular
filtration rate. Total body clearance is similar in
subjects with normal renal function and those with
mild renal impairment (60 to 89 mL/min).
Clearance was reduced approximately 20% in
patients with moderate and severe renal
impairment and was reduced approximately 80%
in patients on dialysis. The ACT should be
monitored in patients with renal impairment.
Bivalirudin is hemodialyzable. Approximately
25% is cleared by hemodialysis.
Dosage
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adjustments are recommended for patients with
moderate-to-severe renal impairment. See
Table 1.
Table 1:
Pharmacokinetics and Dosage
Adjustments ofBivalirudin in Renal Impairment:
Clearance
(mllminlkg)

Half-life
(minutes)

Nonnal (>90 mUmin)
Mild (60-90 mUmin)
Moderate (30-59 mUmin)
Severe (10-29 mUmin)

3.4
3.4
2.7
2.8

25
22
34
57

o/o
Reduction
in
Infusion
Dose
0
0
20
60

Dialysis-dependent
patients (off dialysis)

1

210

90

Renal Function
(GFR, mllmin)

COMPARATIVE EFFICACY:
Angioplasty
Bivalirudin and heparin were compared in a
double-blind trial enrolling 4,098 patients
undergoing angioplasty for unstable or
postinfarction angina (the Hirulog Angioplasty
Study). Bivalirudin or heparin was administered
immediately before angioplasty. Bivalirudin was
dosed as a 1 mg/kg bolus followed by a 4-hour
infusion of 2.5 mglkg/h and a 14- to 20-hour
infusion at a rate of
0.2 mglkg/h. Heparin was dosed as a bolus dose
of 175 units/kg followed by an 18- to 24-hour
infusion at a rate of 15 units/kg/h. The heparin
dose was adjusted based on the ACT drawn at 5
minutes and 45 minutes. Ifthe ACT was less than
350 seconds, the bivalirudin group was given a
bolus of saline and the heparin group was given a
bolus of 60 units/kg of heparin. Aspirin (300 to
325 mg) was given to all patients. The primary
study end point was death, myocardial infarction
(MI), abrupt vessel closure, or rapid clinical
deterioration of cardiac origin during
hospitalization. The incidence of the primary end
point in the intend-to-treat cohort did not differ

between the treatment groups (11.8% with
bivalirudin vs 12.9% with heparin; p=0.26).
Bivalirudin therapy had a lower incidence of
bleeding compared to heparin. Bivalirudin was
associated with a lower incidence of
retroperitoneal hemorrhage (0.2% vs 0.7%,
p=0.02), need for transfusion (3.7% vs 8.6%,
p<O.OOl), and major hemorrhage (3.8% vs 9.8%,
p<0.001). The cumulative rate of death, MI, and
repeated revascularization in the 6 months after
angioplasty did not differ; 25.7% with bivalirudin
and 26.6% with heparin in the intend-to-treat
cohort (p=0.54), and 20.5% with bivalirudin and
25.1% with heparin in the patients with
postinfarction angina (p=0.17). In the subgroup
of 704 patients with postinfarction angina,
bivalirudin therapy was associated with a lower
incidence of the primary end point (9 .1% vs
14.2%, p=0.04) and a lower incidence of major
bleeding (3% vs 11.1%, p<0.001) and minor
bleeding (52.3% vs 68%, p<0.001). As in the
larger study population, rates of death, Ml, and
repeated revascularization in the 6 months
following study drug administration did not differ.
In another subgroup of 567 patients with
thrombus-containing lesions, the incidence of the
primary outcome and 6-month outcomes did not
differ between treatment groups. A reanalysis of
the results of this trial on an intent-to-treat basis
identified 4312 patients, 2161 of whom were
treated with bivalirudin are included in the
product labeling. The reanalysis used a more
sensitive definition ofMI than the original report.
The primary endpoint ofprocedural failure (death,
MI, clinical deterioration of cardiac origin
requiring revascularization or placement of an
aortic balloon pump, or angiographic evidence of
abrupt vessel closure) occurred in 7.9% of
bivalirudin-treated patients compared to 9.3% of
heparin-treated patients.
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Another trial was recently completed comparing
a regimen of abciximab plus aspirin and heparin
with a regimen of aspirin plus intraprocedural
bivalirudin and abciximab if needed in 5,000
patients undergoing routine PTCA with or without
stenting (Comparison of Abciximab
Complications with Hirulog [and Back-Up
Abciximab] Events Trial [CACHET]). Results of
this study have not yet been published. Another
ongoing two-part study is enrolling 1,000 patients
referred for percutaneous coronary interventions
to assess bivalirudin versus heparin, with or
without concomitant glycoprotein lib/lila
inhibitor use, and another 6,000 patients referred
for percutaneous coronary intervention who will
be treated with bivalirudin monotherapy (with
provisional glycoprotein lib/lila inhibitor use),
heparin plus a glycoprotein lib/lila inhibitor, or
bivalirudin plus a glycoprotein lib/lila inhibitor
(The REPLACE Study). Another ongoing study
is currently evaluating bivalirudin in patients
undergoing percutaneous coronary interventions
who are unable to tolerate heparin due to heparininduced thrombocytopenia or heparin-induced
thrombocytopenia and thrombosis syndrome (the
ATBAT 1st Inning Clinical Trial).
CONTRAINDICATIONS, WARNINGS,
AND PRECAUTIONS: Bivalirudin is
contraindicated in patients with active major
bleeding or hypersensitivity to bivalirudin or its
components.
Bivalirudin should not be administered via
intramuscular injection.
Bleeding is the primary adverse effect
associated with bivalirudin. Bleeding can occur
at any site, although when used in the PTCA
setting, bleeding primarily occurs at the site of
arterial puncture. An unexplained fall in blood
pressure or hematocrit, or any unexplained

symptom, should lead to consideration of a
hemorrhagic event and discontinuation of
bivalirudin therapy.
Bivalirudin is in Pregnancy Category B. No
evidence of impaired fertility or harm to the
fetus was apparent in animal studies.
Bivalirudin should be used in pregnancy only if
clearly needed and the impact of the concurrent
aspirin therapy on the fetus and pregnancy needs
to be considered. It is not known if bivalirudin
is excreted in human milk; therefore, caution is
advised when bivalirudin is administered to a
nursing woman.
ADVERSE REACTIONS: Adverse reactions
have included injection site pain, bleeding,
hematoma formation, back pain, nausea,
headache, and hypotension. The most common
adverse effects reported in the Hirulog
Angioplasty Study and the product labeling are
summarized in Table 2. A complete list of the
adverse reactions reported with bivalirudin can
be found in the product labeling.
Table 2: Adverse Effects Occurring in >5% of
Patients in Either Bivalirudin or Heparin
Treatment Group:
Event
Major Bleeding
with >3 g/dL fall in Hgb
requiring transfusion
Cardiovascular
Hypotension
Hypertension
Bradycardia
Gastrointestinal
Nausea
Vomiting
Dyspepsia
Genitourinary
Urinary retention
Miscellaneous
Back pain
Pain
Headache
Injection site pain
Insomnia
Pelvic pain

Anxiety
Abdominal pain
Fever
Nervousness

Bivalirudin
(n=2161)
3.7%
1.9%
2%

Heparin
(n=2161)
9.3%
5.8%
5.7%

12%
6%
5%

17%
5%
8%

15%
6%
5%

16%
8%
5%

4%

5%

42%
15%
12%
8%
7%
6%
6%
5%
5%
5%

44%
17%
10%
13%
6%
8%
7%
5%
5%
4%
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DRUG INTERACTIONS:
Limited drug
interaction data are available at this time.
Pharmacodynamic interactions have not been
apparent in drug interaction studies with
ticlopidine, abciximab, or low molecular weight
heparin. Aspirin does not modify the activity of
bivalirudin.
An increased risk of bleeding exists in patients
receiving heparin, warfarin, glycoprotein lib/lila
inhibitors or thrombolytics in conjunction with
bivalirudin therapy.

RECOMMENDED MONITORING:
In
patients with renal impairment, ACT monitoring
is recommended.
DOSING:
The recommended dosage of
bivalirudin for patients with unstable angina and
NOT CONCURRENTLY RECEIVING A
GLYCOPROTEIN liB/IliA INHIBITOR
scheduled to undergo PTCA is 1 mg/kg as an
intravenous bolus dose followed by a 4-hour
infusion at a rate of 2.5 mg/kg/h. After the
completion of the initial 4-hour infusion, an
additional infusion may be initiated at a rate of
0.2 mg/kg/h for up to 20 hours. Treatment should
be initiated just prior to PTCA. In patients with
renal impairment, the dose should be reduced and
ACT monitored. All patients should receive a 300
to 325 mg dose of aspirin daily. No information
is available on the effectiveness of bivalirudin
without concurrent aspirin therapy.
To prepare bivalirudin for administration, 5 mL of
Sterile Water for Injection should be added to
each 5 mL vial and the contents of the vial gently
swirled until all material is dissolved. Each vial
should be further diluted in 50 mL of 5%
Dextrose in Water or 0.9% Sodium Chloride for
Injection to yield a final concentration of 5
mg/mL (eg, 1 vial in 50 mL, 2 vials in 100 mL, 5

vials in 250 mL). The dose to be administered is
adjusted according to the patient's weight. A table
in the product labeling lists the weight-based dose
in milliliters for the bolus dose and by infusion
rate for the 4-hour and low-dose infusions.
For the low-rate infusion, a lower concentration
bag should be prepared by reconstituting the
250 mg vials with 5 mL of Sterile Water for
Injection and then further diluting the contents in
500 mL of 5% Dextrose in Water or 0.9% Sodium
Chloride for Injection to yield a final
concentration of0.5 mg/mL
Bivalirudin should be administered via an
intravenous line. No other medications should be
mixed with bivalirudin before or during
administration.
CONCLUSION: In the angioplasty setting,
bivalirudin has been demonstrated to be at least
as effective as heparin (and possibly more
effective particularly in patients with recent MI)
and to be associated with a lower incidence of
major bleeding. However, the heparin arm of this
study utilized a very aggressive dosing algorithm
with a target ACT> 350 seconds .. The primary
study end point was death, myocardial infarction
(MI), abrupt vessel closure, or rapid clinical
deterioration of cardiac origin during
hospitalization. The incidence of the primary end
point in the intend-to-treat cohort did not differ
between the treatment groups (11.8% with
bivalirudin vs 12.9% with heparin; p=0.26). The
cumulative rate of death, MI, and repeated
revascularization in the 6 months after angioplasty
did not differ; 25.7% with bivalirudin and 26.6%
with heparin in the intend-to-treat cohort (p=0.54),
and 20.5% with bivalirudin and 25.1% with
heparin in the patients with postinfarction angina
(p=0.17). Therefore, routine use of this agent in
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and 20.5% with bivalirudin and 25.1% with
heparin in the patients with postinfarction angina
(p=0.17). Therefore, routine use of this agent in
lieu of unfractionated heparin cannot be
recommended .
However, for patients unable to tolerate heparin
or at a high risk for major bleeding, bivalirudin
use may be the preferred agent, as neither
lepirudin or argatroban have FDA approved
indications, and bivalrudin may be less costly than
either of the other two direct thrombin inhibitors.
More data are necessary on the use ofbivalirudin
in additional settings and in combination with
other agents, particularly glycoprotein lib/lila
inhibitors, clopidogrel, and thrombolytics before
widespread use can be advocated. The CACHET
and REPLACE trials will provide some guidance
in this area. A patient treatment would cost (at a
minimum) $350. Dosing is predicated on a
patient's weight and duration of therapy can also
vary significantly, thereby, effecting treatemnt
costs.
The Therapeutics Committee recommend
approval for this agent for use in patients with
documented previous heparin induced
thrombocytopenia. Use with glycoprotein lib/lila
agents will require dosing adjustments.

Esclim patches

were selected as the
preferred estrogen-based patch. The Pharmacy
will use this patch system to provide a basis for an
automatic therapeutic substitution for all other
currently available estrogen-based patch systems.
These products were considered interchangeable
as far as efficacy and safety were concerned.

coma!!]§QnOfTransdennal Estro2en Thcraoies

VivelleDOT
Twice
weekly
0.375
0.05
O.o75
0.1

Brand name

Estradenn

Climara

Vivelle

Alora

Dosage
regimen
Available
strengths
(mgld)

Twice
weekly
0.05
0.1

Once
weekly
0.025
0.05
O.o75
0.1

Twice
weekly
0.375
0.05
0,075
0.1

Twice
weekly
0.05
O.o75
0.1

Placement

Abdomen,
buttocks

Abdomen,
buttocks

Abdomen,
buttocks

Abdomen,
buttocks

Acutal
weighted
cost/month •
Hospital
Acqusition
cost-each

$20.24

$21.38

$21.65

Abdomen,
hip,
buttocks
$18.23

$2.45$2.67

$2.54$2.76

$2.62$2.78

$2.21$2.38

$2.68$2.84

$22.18

Esclim
Twice
weekly
0.025
0.0375
0.05
0.075
0.1
Buttocks,
thigh,
arm
$19.60

$0.01

*Source: First Databank, Inc,: First DataBank Pricing Database, 4/2000

Fenojibrate rejected
At the last therapeutics committee meeting, data
were presented that demonstrate no clinical
advantage offenofibrate (tricor) over the currently
available fibric acid derivative at LVH
(gemfibrozil). Although never compared head to
head, these two agents have comparable effects on
serum lipids. The adverse effect profile of both
agents is nearly identical. In light of this data the
recommendation of the committee is to not add
fenofibrate to formulary. There appears to be no
clinical advantage over gemfibrozil other than
once daily dosing. No data are available on the
effects of fenofibrate on morbidity and mortality
from coronary artery disease. Other fibrates have
shown a slowing of the progression of coronary
artheroscelrosis and a decrease in the incidence of
coronary events, but no effect on total mortality.
There may be more data in the near future. The
committee voted to allow the substitution of
gemfibrozil600 mg bid for fenofibrate in doses of
67-200 mg/day.

Medication Error Prevention Tips
See attached sheet for some examples.
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Medication Error Preventions
·-

Abbreviation/
Dose Expression

Intended

.
o not use these dan'lf!erous abbreviations or d ose d esl[!natwns
~isinterpretation

~eanrnng

Apotheca1y symbols dram
minim
AU

aurio uterque (each ear)

DIC

discharge
discontinue

Misunderstood or misread (symbol for
dram misread for "3,. and minim
misread as "mL").
Mistaken for OU (oculo uterque-each
eye).
Premature discontinuation of
medications when D/C (intended to
mt::au

··uis~,.;llargt::" ")

Correction

Use the metric
system.
Don't use this
abbreviation.
Use "discharge" and
"discontinue ..,

lias lJt::t::Il

misinterpreted as "discontinued" when
followed by a list of drugs.
Drug names
ARA-A
.AZT
CPZ

vidarabine
zidovudine (RETROYm)
COMPAZINE

cytarabine (ARA-C)
azathioprine
chlorpromazine

Use the complete
spelling for drug
names.

(prochlorperazine)
DPT

DEMEROL-PHENERGAN- diphtheria-pertussis-tetanus (vaccine)
THORAZINE

HCl

hydrochloric acid
hydrocortisone
hydrochlorothiazide
magnesium sulfate
morphine sulfate
methotrexate
triamcinolone
zinc sulfate

potassium chloride (The "H" is
misinterpreted as "K. ")
hydrochlorothiazide
hydrocortisone (seen as HCT250 mg)
morphine sulfate
magnesium sulfate
mitoxantrone
tetracaine, ADRENALIN, cocaine
morphine sulfate

nitroglycerin infusion

sodium nitroprusside infusion

IJ.g

microgram

Mistaken for "mg" when handwritten.

Use "meg."

o.d. or OD

once daily

Use "daily."

TIW ortiw

three times a week

Misinterpreted as "right eye" (ODoculus dexter) and administration of
oral medications in the eve.
Mistaken as "three times a day."

per os

orally

q.d. or QD

every day

lqn
qhs

nightly or at bedtime
nightly at bedtime

The "os" can be mistaken for "left
eve."
Mistaken as q.i.d., especially ifthe
period after the "q" or the tail ofthe
"q" is misunderstood as an "i."
Misinterpreted as "qh" (everv hour).
Misread as every hour.

!q6PM, etc.

every evening at 6 PM

Misread as every six hours.

HCT
HCTZ
MgS04
MS04
MTX
TAC
ZnS04
Stemmed names
"Nitro" drip

I

Don't use this
abbreviation.
Use "PO," "by
mouth," or "orally."
Use "daily" or "every
day."
Use "nightly."
Use "nightly."
Usc 6 PM "nightly."
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. at'zons
do not use th ese angerousahhrevzatzons or tJose tJeszgnj
Correction
Misinterpretation
Intended Meaning

Abbreviation/
Dose Expression
q.o.d. or QOD

every other day

sub q

subcutaneous

sc

subcutaneous

U oru

unit

Read as a zero (0) or a four (4),
causing a 10-told overdose or greater
(4U seen as "40" or 4u seen as 44").

IU
cc

international unit
cubic c~nlim~l~rs

Misread as IV (intravenous).
Misr~ad as "U" (unils).

Use "subcut." or write
"subcutaneous."
"Unit" has no
acceptable
abbreviation. Use
"unit."
Use "units."
Us~ "mL."

x3d

for three days

Mistaken for "three doses."

Use "for three days."

BT

bedtime

Mistaken as "BID" (twice daily).

Use "hs."

Misinterpreted as "q.d." (daily) or
"q.i.d. (four times daily) if the "o" is
poorly written.
The "q" has been mistaken for "every"
(e.g., one heparin dose ordered "sub q
2 hours before surgery" misunderstood
as every 2 hours before surgery].
Mistaken for SL (sublingual).

Use "every other
day."
Use "subcut." or write
"subcutaneous."

Spell out ..sliding
scale." Use "one-half'
or use " 1h."
>and<
greater than and less than Mistakenly used opposite of intended. Use "greater than" or
"less thn.n."
I (slash mark)
Do not use a slash
separates two doses or
Misunderstood as the number 1 ("'25
mark to separate
indicates "per"
unit/10 units" read as "110" units.
doses.
Use "per."
Always use space
Name letters and
Misread as Inderal 140 mg.
Inderal 40 mg
dose numbers run
between drug name,
together
dose and unit of
!(e.g., Inderal40 mg).
measure.
Zero after decimal 1 mg
Misread as 10 mg ifthe decimal point Do not use terminal
point (1.0)
is not seen.
zeros for doses
expressed in whole
numbers.
No zero before
Always use zero
0.5 mg
Misread as 5 mg.
decimal dose
before a decimal when
(.5 mg)
the dose is less than a
whole unit.
ss

sliding scale (insulin)
or 1h (apothecary)

Mistaken for "55.''
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A Targeted, Multidisciplinary Approach to Improving Patient Care
In the fall of 1999, the Institute of Medicine published To Err Is Human, which focused on
building a safer health system through process and human factors analysis, improving error
reporting systems, setting performance standards, and creating "systems of safety" in health care
organizations.
In response to the 10M's report, LVHHN embarked upon a multidisciplinary, systems approach
to improving care and reducing medical errors: the Primum Non Nocere projects for FYOl.
These "First Do No Harm" projects are focused, practical approaches to improving care through:
1) improved communication
2) fail-safe process design
3) evidence-based protocol use
In March 2001, the Institute of Medicine released its second report on health care, "Crossing the
Quality Chasm". The report states that health care should be:
1) safe
2) effective
3) patient-centered
4) timely
5) efficient
6) equitable
To address systems issues and adhere to these 6 principles, we have created the Multidisciplinary
Council. This quality assurance council reviews select QA cases and develops hospital-wide
systems solutions. In addition, as we move forward with FY02 PNN projects, we continue to
keep these principles in mind.
Primum Non Nocere
SOME PROJECT HIGHLIGHTS
Fluid overload reduction
Diabetes management
perioperatively
DVT/PE***
IV infections
Atrial fibrillation
Falls
Unplanned returns to OR
Blood use
Medication errors
UTI reduction
Decubitus ulcers
Needlesticks
Site identification team

Improve weight documentation and fluid overload
management/Communicate wt change >3lbs to physician
Use of preprinted order sets
Improve heparin order sheet use/Decrease DVTs/PE/Use blue bands
for patients on any anticoagulation
Decrease complications
Improve postop management
Decrease risk of falls
Decrease incidence
Improve preprinted order use/Decrease waste
Improve medication error reporting/Non-punitive reporting
policy/Safer pain management with PCA/epidural pumps
Decrease Foley catheter use/Institute urinary retention protocol/Use
bladder scanners
Decrease incidence. Institute Braden scale for monitoring
Improve patient and employee safety with safer devices
Institute protocols for proper surgical site identification
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***A word on DVT and PE complications***
This project focuses on appropriate treatment of patients with these diagnoses, and on proper
prophylaxis of patients to avoid DVT/PE in the hospital. Our institutional average incidence of
DVT as a secondary diagnosis is less than one percent (FYOl data); however, some individual
departments and divisions have rates that exceed this by 200%. Improvements can be best
accomplished by using preprinted orders for anticoagulation in patients at risk for DVT/PE. As
Dr. Mark Cipolle comments, "Chart reviews indicate that as many as 50% of patients who
develop DVT as a complication did not have appropriate prophylaxis in our institution. There is
a large amount of treatment variation for DVT/PE; we will be striving to reduce this variation,
and will encourage the use of LMWH."
Your cooperation with preprinted order use, reporting of preventable adverse events through the
Event Report process, legible orders and printed names or stamps (available through Medical
Staff services), and pro-active identification of patient and employee safety issues, will ensure
everyone's success in improving patient care. Finally, CAPOE is coming!
Please contact Zubina M. Mawji, MD, MPH with your ideas or questions on specific projects at
610-402-5015.

C/mydocuments/prognotS-0 1
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May 2001

News from the Library
OVID Training.
The Library has completely converted to OVID's online MEDLINE system. This Web-based system is
updated daily by Ovid. Call Barbara Jobst in the
Health Sciences Library at 610-402-8408 to schedule
a one-on-one training session.

New Library Publications.
CC &I-78
"Heart Disease: A Textbook of Cardiovascular
Medicine," 6th edition.

L VH-Muhlenberg
"Krause's Food, Nutrition, and Diet Therapy," lOth
edition.
"Harrison's Principles of Internal Medicine," 15th edition.

CBT programs replace the instructor-led classes previously
held at Lehigh Valley Hospital. A proctor will be in the room
with the learner while he/she takes the CBT, but the learner
will control the pace and objectives of the learning.

Computer Based Training takes place in Suite 401 of the John
& Dorothy Morgan Cancer Center (the computer training
room) and in the Muhlenberg Hospital Center computer
training room (off the front lobby). The schedule of
upcoming dates is as follows:

CBT sessions for JDMCC, suite 401 are as follows:
June 26, Noon- 4 pm
August 7 8 am - Noon

Sessions at MHC, I.S. Training room are as follows:
17th & Chew Streets
"Principles and Practice of Emergency Medicine," 4th
edition.
"Psychiatric Clinics of North America"- Volume 24,
No.1
Topic: Generalized Anxiety Disorder.

Computer-Based Training (CBT):
Computer Based Training (CBT) programs are available for
L VHHN staff. Topics covered by the CBT programs include:
Access 2.0
Power-Point 4.0
Windows NT 4
Word 97
Excel 97
Access 97
PowerPoint 97
Lotus 1-2-3 Millennium
WordPerfect 8
E-mail GUI
PHAMIS LastWord Inquiry Only commands

1

July 17,

Noon- 4 pm

Twelve slots are available for each session.
To register, please contact Suzanne Rice via e-mail or at 610402-2475 with the following:
date of session
second date choice
department
phone number
You will receive an e-mail confirming your choice within two
business days. If you have any questions, please contact Craig
Koller at 610-402-2413 or through e-mail.

Any questions, concerns or comments on articles from CEDS, please
contact Bonnie Schoeneberger 610-402-2584

Page24
Educational Activities
Obstetrics & Gynecology,
Joseph A. Miller, M.D.
Resident Research Day
Friday, June 1, 2001
Lehigh Valley Hospital
Cedar Crest & 1-78, Auditorium
7:30am Registration/Continental Breakfast
8:00 am Opening Remarks
Vincent Lucente, MD, MBA, FACOG
8:05 am Welcome Remarks
Robert Laskowski, MD, MBA
Scientific Session- Moderator: Orion Rust. MD. FACOG
8:10 am Ancient Egyptian Medicine and Lessons for Today
State of the Union for ACOG
W. Benson Harer, Jr., MD, FACOG
9:10am Concomitant Vaginal Surgery with Tension-Free
Vaginal Tape Pubovaginal Sling for the Treatment
of Female Stress Urinary Incontinence and Pelvic
Support Defects
T. Russell Horton, MD
9:40 am

Evaluation of a Resident-Run Community Service
Project
Rochelle Steiner, MD

10:30 am Early Feeding After Gynecologic Surgery: An
Evidence-Based Talk
Fidel Valea, MD, FACOG
11:30 am Clinical Outcomes of the Fetus with Preterm
Premature Rupture of Membranes <30 weeks
Eric Grossman, MD
12:00 pm Treatment of the Macrosomic FetusAraba Sam, MD
12:30 pm Closing Remarks
Orion Rust, MD, FACOG

2

Audience:

Attending physicians, residents, medical students, nurses and
other healthcare professionals are invited to continue their
career development and medical education by attending this
educational offering.
ObJectives:

At the completion of this program, the participant will be able
to: compare how the science of medicine has changed but
human nature has not; and evaluate evidence-based
recommendations regarding early feeding after gynecologic
surgery.
Accreditation:

Lehigh Valley Hospital and Health Network is accredited by
the Pennsylvania Medical Society to sponsor continuing
medical education programs for physicians.
Lehigh Valley Hospital and Health Network designates this
continuing medical education activity for 4 credit hours in
Category 1 of the Physician's Recognition Award of the
American Medical Association and the Pennsylvania Medical
Society membership requirement.
All faculty participating in continuing medical education
programs sponsored by Lehigh Valley Hospital and Health
Network are expected to disclose to the program audience any
real or apparent conflicts of interest related to the content of
their presentations.
Registration:

There is no registration fee for this program.
To register, e-mail Bonnie.Schoeneberger@lvh.com the
following information:
Name, Title (MD, DO, RN or other)
Company and department
Address
Day time phone
Social Security Number
For questions or for more information:
E-mail Bonnie.Schoeneberger@lvh.com or call Bonnie @
610-402-2584.

* * * * * * * * * * * * * * * * * * *
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TRAUMA NURSE COURSE

ONCOLOGY EDUCATION SERIES:
BREAST CANCER UPDATE

Module I - Principles of Care
This is a self-learning package that needs to be completed
prior to attending any modules of the course. Please register
for this the same as all other modules. The "Principles of
Care" book, exam and evaluation will be mailed to you. Please
allow at least two weeks for completion. Exams and
evaluations must be returned by May 28, 2001.
Adult Trauma
Day 1

6/4/01 0800-1630

EMI

Topics Covered:
Trauma System Overview
Pain Management Principles
Shock/Anesthesia with METI Simulator
PCA/Epidural
Pregnant Trauma Patient
Maxillofacial Trauma
Head Injury
SCI Injury and Assessment
Ethical Dilemmas
Day 2

6/5/01 0800-1630

JDMCC CONFERENCE ROOM 1N1B
Agenda:
7:30am Registration
7:45 am Overview of Breast Cancer
Elisabeth Ladd, RN, MSN
8:45 am New Imaging Modalities in the Diagnosis of
Breast Cancer- Dr. John Pearce
9:45 am Advances in the Staging of Breast Cancer: Sentinel
Node Biopsy -Dr. Gerry Sherwin
10:30 am Break
10:45 am Pathological Advances in the Diagnosis and
Staging of Breast Cancer - Dr. Elizabeth Dellers
11:30 am Breast Cancer Prevention/STAR
Deborah Kane, RN, BS
12:00 pm Lunch
12:45 pm Cancer Genetics- Elisabeth Ladd, RN, MSN
1:30pm Breast Reconstruction- Dr. Samina Wahhab

Pediatric Trauma 6/6/01 0800-1630 EMI
Topics Covered:
Intro to Pediatric Trauma
Pediatric Head Injury
Pediatric Chest/Thoracic
Pediatric MS Injuries
Pediatric Abdominal Injuries
Pediatric IV Therapy/Fluid Management Workshop
Part I - IV Therapy
Part II - Fluid and Medication Calculation
Skill Stations:
Pediatric Resuscitation/Shock and Anesthesia
Pain Management
Spinal Cord Injury
Child Abuse
Family Crisis Intervention
6/7/01

7:30AM-4:15PM

EMI

Topics Covered:
Chest Trauma
AbdominaVGU Trauma
MS Trauma
Complications of Trauma
Burn Injury
Organ Donation

Burn Trauma

JUNE 6,2001

0800-1630

2:15 pm Break
2:30pm

What Are Our Patients Telling Us?
Nadesda Mack, RN, BSN

3:15pm

Survivors' Perspective

4:00 pm

Summary and Evaluation

Accreditation:
Lehigh Valley Hospital and Health Network is approved as a
provider of Continuing Nursing Education (CNE) as approved
by the Pennsylvania Nurses Association, an accredited
approver of continuing education in nursing by the
American Nurses Credentialing Center's Commission on
Accreditation. This course has been approved for 8.7 PSNA
Contact Hours for registered nurses attending the entire
program and completing the evaluation tool.

EMI
To Register: See **Registration Information Below**

To Register: See **Registration Information Below**

* * * * * * * * * * * * * * * * * * *
3

********************** ***
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LVHHN AND EASTERN PA CHAPTER AANN
Present•••
NEURO EVENING SEMINAR
Wednesday, June 6, 2001
5:00pm- 8:30pm
Lehigh Valley Hospital Auditorium, CC & 1-78
Schedule:
4:30pm

Registration

5:00pm

Pain Management in MS
Nancy Eckert & Stacy Statler

6:00 pm

Break

6:15 pm

Neuroscience and Socialized Medicine
Dr. Mark Lester

7:15pm

Dysphagia After Cervical Surgery
Claranne Mathiesen and Patty Schlegel

8:15pm

Evaluation

Accreditation:
Lehigh Valley Hospital and Health Network is approved as a
provider of Continuing Nursing Education (CNE) as approved
by the Pennsylvania Nurses Association, an accredited
approver of continuing education in nursing by the
American Nurses Credentialing Center's Commission on
Accreditation. This course has been approved for 3.9 PSNA
contact hours for registered nurses attending the entire
program and completing the evaluation tool.

4

**Register Information: **
THERE IS NO FEE TO ATTEND THESE PROGRAMS.
LVHHNStatT
Please access the Bulletin Board entitled Forms_Nursing.
Select the Cont. Education Registration Form.
Right click on the title and choose "Use Form".
Complete all areas (refer to "How To Register" for more help
on using forms).
Use the comments section to provide us with any additional
information that may be useful.
We will be unable to process incomplete registrations.
PennCARE Affiliates and Staff without E-Mail Access
Please either call (610-402-2277) or fax (610-402-2203) the
following information: name, hospital affiliation, position,
mailing address, social security#, and daytime phone#.
We will be unable to process incomplete registrations.

If you have any questions, please call the Center for
Educational Development and Support at 610-402-2277.

Any questions, concerns or comments on articles from CEDS, please
contact Bonnie Schoeneberger 610-402-2584

Monday

Sunday

Tuesday

Thursday

Wednesday

1

June 2001

3
10
17
24

4

5

6

7

7am Family Practice GRJDMCC - 1A/1 B
7am Surgical GR-CC-Aud
Bam Pediatric GR- CC-Aud
12 noon Medical GR-CCAud

730am- 4:15pm Breast
Cancer Update JDMCC 1A/1B
5:00pm - 8:30 pm Neuro
Evening Seminar CC Aud

12noon Combined TBJDMCC-CR1

11

12

13

14

7am Surgical GR-CC-Aud
Bam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud

12noon Pulmo TBJDMCC-CR1

12noon Gl TB-JDMCC
CR-1

20

18

19
Bam Pediatric GR-CC-Aud

25

26
Sam Pediatric GR-CC-Aud
12noon Urology TB-JDMCCCR1

31

27

Saturday

2

730am -12:40 pm
Resident Research Day
CC- Aud
12noon Breast TB-JDMCCCR1

12noon Colon/Rectal
TB-JDMCC-CR1

12noon Colon/Rectal
TB-JDMCC-CR1

Friday

8

9

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

15

16

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

22

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

23

12noon ENT TBJDMCC-CR1

28

29

30

21
12noon Combined TB CC- Aud

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1
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